700 patients110,866 observations180 daysLIVE

Patient P-02343

Synthetic patientMETA-24 · Day 173 · 75+ · M · baseline S03Steering view · 3DOpen companion preview
Therapy response
Unstable
Tolerance
Favorable
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Improving
Discontinuation risk
13%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 startedBaseline state S03
  2. Day 127 Trajectory diverged from predictionObserved response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 127.

Primary contributors, last 14 days
  • GI instability-13
  • Nutritional resilience+8
  • Inflammatory activity-6
  • Treatment adherence+3

What helped?

No interventions yet.

    LIFE OS recommendation
    No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    Active minutes
    Wearable
    80 min
    stable · -1.6 vs previous 14 d
    Sleep duration
    Wearable
    6.1 h
    stable · -0.2 vs previous 14 d
    Energy level
    Daily log
    5.2/10
    stable · +0.0 vs previous 14 d
    Steps
    Wearable
    8,317
    worsening · -361 vs previous 14 d
    GI burden
    Companion
    13.4/100
    improving · -3.1 vs previous 14 d
    Adherence
    Companion
    79.2 %
    worsening · -4.8 vs previous 14 d
    Sleep quality
    Wearable
    30.5/100
    stable · +0.9 vs previous 14 d
    Glucose, CGM daily mean
    CGM
    140 mg/dL
    stable · -0.3 vs previous 14 d
    This trajectory is doing well — what to keep, what to watch
    Steering view →

    Heading towards restoration · 72 from the failing basin, 44 from restoration.

    Good elements to keep
    • Butyrate producers intact
      hidden · steering +7.5
    • Protein (supports)
      perturbation · steering +7.1
    • Daily walks resumed
      perturbation · steering +3.3
    • Protein
      supporter · GI -3.8 next day
    Main detractors to watch
    • FUT2 non-secretor
      hidden · steering -10.6
    • Bacteroides fragilis elevated
      hidden · steering -7.4
    • Antibiotic course
      perturbation · steering -4.7
    • Histamine load
      perturbation · steering -4.5
    • Histamine load
      detractor · GI +2.8 next day
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Protein
      -3.8supporter · 95%
    • Histamine load
      +2.8detractor · 81%
    • Dietary fat load
      -1.2no signal · 18%
    • Simple carbohydrates
      -1no signal · 29%
    • Alcohol
      +1no signal · 33%
    • Caffeine
      +0.9no signal · 22%
    • Insoluble fibre
      -0.6no signal · 16%
    • Ultra-processed food
      -0.3no signal · 15%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Mucosal barrier integrity 70
      • DNAFUT2 non-secretor lowers mucosal fucosylation
      • MicrobiomeAkkermansia low → thinner mucus layer
      • WearableSleep 6.1 h, below personal baseline
    • Inflammatory signalling 35
      • MicrobiomeBacteroides fragilis expansion
      • WearableHRV 34 ms, trending down
    • Butyrate / short-chain fatty acid production 25
      • MicrobiomeF. prausnitzii depleted
    • Autonomic recovery 20
      • WearableShort sleep window
    DNA
    Fictional pharmacogenomic panel
    • FUT2 rs601338 AA (non-secretor)
      Reduced mucosal fucosylation
    • CYP2D6 Normal metabolizer
      Expected exposure
    • GLP1R rs6923761 A
      Altered receptor sensitivity
    • MTHFR C677T
      Reduced folate turnover
    Microbiome
    Shannon diversity 3 · butyrate capacity 56/100
    • Akkermansia muciniphilaLow
    • Faecalibacterium prausnitziiLow
    • Bacteroides fragilisHigh
    • Bifidobacterium longumNormal
    • EnterobacteriaceaeNormal
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    41 ms
    Sleep
    6.0 h
    Steps
    6,928
    Resting HR
    71 bpm
    Daily log: GI score 13, nutritional resilience 71, adherence 79.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Keep meals regular; three to four moderate portions spaced through the day
    • Include a cooked vegetable portion with each main meal
    • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
    • Eat slowly and stop at comfortable fullness — smaller volume, more often
    What to do
    • Log the daily check-in; one line is enough
    • Keep the current walking rhythm
    • Protect a 7.5-hour sleep window; screens off 30 minutes before
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the dose at the same time relative to your evening meal
    • No additional supplements this week
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0228546%S14AD-05no change39
    P-0209345%S05AD-05no change40
    P-0203141%S12AD-05improved47
    P-0255240%S07AD-05no change29
    P-0232547%S19BR-03no change33
    P-0252244%S01BR-03no change40
    P-0208740%S01BR-03no change40
    P-0243939%S08BR-03no change40
    P-0226738%S09BR-03no change45
    P-0230837%S13BR-03no change27
    P-0256437%S15BR-03improved32
    P-0233131%S14BR-03improved34